Welcome to NeuroMab!
The UC Davis/NIH NeuroMab Facility is a purely academic monoclonal antibody (mAb) facility with a mission to generate mouse mAbs extensively validated for use in mammalian brain, as funded by NIH awards U24 NS050606 (2005-2015), R24 NS092991 (2015-2019) and U24 NS109113 (2019-present).
The NeuroMab collection (both the mAbs and the hybridoma cells that produce them) is available from the Developmental Studies Hybridoma Bank (DSHB) at the University of Iowa.
NeuroMab hybridomas are also available from the UC Davis MMRRC.
Recombinant mAbs derived from the NeuroMab collection are available from Addgene as plasmids and, as funded by BRAIN Initiative award NIH U24 NS119916, as ready-to-use antibodies.
The sequences of the heavy and light chain variable domains of most NeuroMabs are now available on the NeuroMabSeq website here. These sequences were obtained by high-throughput sequencing of hybridoma-derived RNA as funded by BRAIN Initiative award NIH U24 NS109113. See our recent publication here.
NeuroMabs are validated for biochemical and immunohistochemical applications in mammalian brain samples, including immunoblotting, immunohistochemistry and array tomography. For information on NeuroMab validation see Gong et al., New Biotech 33:551, 2016. PubMed. See detailed sample preparation and labeling protocols used for NeuroMab monoclonal antibody validation.
NeuroMab is a proud supporter of the Research Resource Identification (RRID) initiative. Our unique identifier is RRID:SCR_003086.
For perspectives on application-specific antibody validation see Taussig et al., New Biotech 45:1, 2018. PubMed.
See publications list for peer-reviewed papers showing data obtained with NeuroMabs, now over >6,300 publications!
![]() | ![]() | ![]() |
![]() | ![]() | ![]() |





